The 2.4 million rapid COVID-19 screening tests on the shelf can finally be deployed in Quebec “in a prudent manner”.
• Read also: COVID-19: Rapid tests to prevent outbreaks in schools
This is what an expert committee formed by the government ruled in its report released on Thursday.
” […] These rapid PDS technologies have the advantage of delivering immediate results. Deployed intelligently and cautiously, these rapid diagnostic tests can have a prominent place in the control of the pandemic, ”it was pointed out.
We recommend the deployment of these rapid tests in regions poorly served by current devices, in designated screening clinics where capacity is limited, or by teams dedicated to the management of outbreaks in living environments for the elderly. , provided that the devices prove to be sufficiently resistant.
Earlier this week, Minister Christian Dubé clarified that screening is doing well in Quebec and that the use of rapid tests to massively diagnose COVID-19 in schools and workplaces is not necessary at this stage. this. “Right now, we don’t need it,” he said before adding that these devices are less reliable than laboratory analysis.
Three types of rapid tests are available: a nucleic acid amplification test called ID NOW and two antigen tests, Panbio and BD Veritor. So far, only 6,500 have been used.